Holen Sie sich die Stockscreener-App
85.27
1.62%
-1.40
Handel nachbörslich:
85.23
-0.04
-0.05%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt EW?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$86.67
Offen:
$86.6
24-Stunden-Volumen:
2.64M
Relative Volume:
0.60
Marktkapitalisierung:
$49.48B
Einnahmen:
$5.88B
Nettoeinkommen (Verlust:
$1.34B
KGV:
36.30
EPS:
2.3489
Netto-Cashflow:
$799.60M
1W Leistung:
+0.66%
1M Leistung:
+3.42%
6M Leistung:
+9.01%
1J Leistung:
+19.51%
1-Tages-Spanne:
$85.17
$86.93
1-Wochen-Bereich:
$84.66
$87.40
52-Wochen-Spanne:
$65.94
$87.40
Edwards Lifesciences Corp Stock (EW) Company Profile
Firmenname
Edwards Lifesciences Corp
Sektor
Branche
Telefon
(949) 250-2500
Adresse
ONE EDWARDS WAY, IRVINE, CA
Vergleichen Sie EW mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EW
Edwards Lifesciences Corp
|
85.27 | 50.29B | 5.88B | 1.34B | 799.60M | 2.3489 |
|
ABT
Abbott Laboratories
|
128.01 | 224.14B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
101.01 | 150.59B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
372.32 | 141.95B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
103.34 | 135.03B | 34.76B | 4.79B | 5.21B | 3.7017 |
Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2025-10-29 | Hochstufung | Jefferies | Hold → Buy |
| 2025-10-29 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2025-10-08 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-10-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-07-29 | Hochstufung | BTIG Research | Neutral → Buy |
| 2025-04-24 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-01-30 | Hochstufung | Stifel | Hold → Buy |
| 2025-01-16 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2024-12-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-10-11 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-09-18 | Herabstufung | Jefferies | Buy → Hold |
| 2024-07-31 | Hochstufung | Daiwa Securities | Neutral → Outperform |
| 2024-07-29 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2024-07-25 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-07-25 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-07-25 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-07-25 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-07-25 | Herabstufung | Truist | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2024-05-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-05-14 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-03-07 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-02-02 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-11-28 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2023-09-26 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-03-08 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-02-06 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-01-31 | Herabstufung | Bernstein | Outperform → Underperform |
| 2023-01-30 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-12-06 | Herabstufung | Stifel | Buy → Hold |
| 2022-10-28 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-10-26 | Eingeleitet | Mizuho | Buy |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-29 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-03-16 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2022-02-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-27 | Bestätigt | Citigroup | Buy |
| 2022-01-27 | Bestätigt | Evercore ISI | Outperform |
| 2022-01-27 | Bestätigt | Raymond James | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Buy |
| 2022-01-27 | Bestätigt | UBS | Neutral |
| 2021-12-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-12-15 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-12-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-07-30 | Bestätigt | Canaccord Genuity | Buy |
| 2021-07-30 | Bestätigt | Deutsche Bank | Hold |
| 2021-07-30 | Bestätigt | Jefferies | Buy |
| 2021-07-30 | Bestätigt | Morgan Stanley | Overweight |
| 2021-07-30 | Bestätigt | Oppenheimer | Outperform |
| 2021-07-30 | Bestätigt | Stifel | Buy |
| 2021-07-30 | Bestätigt | UBS | Neutral |
| 2021-07-30 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Neutral |
| 2021-04-05 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-12-16 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-11 | Bestätigt | Canaccord Genuity | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Underperform |
| 2020-04-28 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-04-17 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Neutral |
| 2020-02-06 | Fortgesetzt | BTIG Research | Neutral |
| 2020-01-10 | Eingeleitet | Oppenheimer | Outperform |
| 2020-01-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-10-24 | Bestätigt | Canaccord Genuity | Buy |
| 2019-09-23 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-07-24 | Bestätigt | BofA/Merrill | Buy |
| 2019-03-18 | Bestätigt | Canaccord Genuity | Buy |
| 2019-01-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Hold |
| 2018-11-28 | Eingeleitet | UBS | Neutral |
| 2018-10-16 | Eingeleitet | Barclays | Underweight |
| 2018-10-02 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2018-10-02 | Herabstufung | Guggenheim | Buy → Neutral |
Alle ansehen
Edwards Lifesciences Corp Aktie (EW) Neueste Nachrichten
New York State Common Retirement Fund Sells 29,484 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Norges Bank Takes Position in Edwards Lifesciences Corporation $EW - MarketBeat
Quadrant Capital Group LLC Grows Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
HALPER SADEH LLC ENCOURAGES EDWARDS LIFESCIENCES CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - Finviz
State Board of Administration of Florida Retirement System Sells 3,837 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Korea Investment CORP Has $36.33 Million Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Laurel Wealth Advisors LLC Raises Position in Edwards Lifesciences Corporation $EW - MarketBeat
First National Advisers LLC Buys 9,644 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation (NYSE:EW) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Edwards Lifesciences Corporatio (EW) Stock forecasts - Yahoo Finance UK
Steward Partners Investment Advisory LLC Has $6.86 Million Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Stock Position Raised by United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund - MarketBeat
Northwest & Ethical Investments L.P. Boosts Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
69,100 Shares in Edwards Lifesciences Corporation $EW Bought by Employees Retirement System of Texas - MarketBeat
Edwards Lifesciences (NYSE:EW) Sets New 12-Month HighShould You Buy? - MarketBeat
Russell Investments Group Ltd. Raises Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Rhenman & Partners Asset Management AB Takes $4.30 Million Position in Edwards Lifesciences Corporation $EW - MarketBeat
RiverPark Advisors LLC Has $795,000 Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Angiostomy Cannula Market to Get an Explosive Growth | Edwards - openPR.com
Edwards Lifesciences' (NYSE:EW) investors will be pleased with their 20% return over the last year - Yahoo Finance
Elo Mutual Pension Insurance Co Reduces Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences stock reaches 52-week high at 87.25 USD By Investing.com - Investing.com Nigeria
Edwards Lifesciences stock reaches 52-week high at 87.25 USD - Investing.com India
BTIG Research Reiterates "Buy" Rating for Edwards Lifesciences (NYSE:EW) - MarketBeat
Edwards Lifesciences Corporation $EW Stock Holdings Boosted by Edmond DE Rothschild Holding S.A. - MarketBeat
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MarketWatch
Edwards Lifesciences (EW) Analyst Rating Reiterates Buy with $10 - GuruFocus
Journey Strategic Wealth LLC Takes Position in Edwards Lifesciences Corporation $EW - MarketBeat
Rhumbline Advisers Sells 34,159 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Shares Sold by Mediolanum International Funds Ltd - MarketBeat
Edwards Lifesciences Corporation (EWLS.VI) Stock Price, News, Quote & History - Yahoo! Finance Canada
Legal & General Group Plc Sells 269,910 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Swiss National Bank Raises Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Handelsbanken Fonder AB Buys 139,909 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
DNB Asset Management AS Reduces Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Wolfe Research Downgrades Edwards Lifesciences (EW) - MSN
Prudential PLC Has $9.36 Million Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
SG Americas Securities LLC Decreases Position in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Stock Position Decreased by Bank Julius Baer & Co. Ltd Zurich - MarketBeat
Edwards Lifesciences Corp. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Howe & Rusling Inc. Has $6.64 Million Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
GDS Wealth Management Increases Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Is Edwards Lifesciences Corporation (EWL) stock a top dividend aristocrat candidateFed Meeting & Reliable Price Action Trade Plans - newser.com
Edwards Lifesciences Corporation $EW Shares Sold by Nomura Asset Management Co. Ltd. - MarketBeat
Vanguard Group Inc. Grows Position in Edwards Lifesciences Corporation $EW - MarketBeat
Will Edwards Lifesciences Corporation (EWL) stock rise with strong economyJuly 2025 News Drivers & Risk Adjusted Buy/Sell Alerts - newser.com
Primecap Management Co. CA Acquires 1,147,291 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Highview Capital Management LLC DE Cuts Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Stock Holdings Cut by Intech Investment Management LLC - MarketBeat
Why Edwards Lifesciences Corporation stock remains a top recommendationJuly 2025 Outlook & Daily Momentum Trading Reports - newser.com
Tick level data insight on Edwards Lifesciences Corporation volatilityTrade Entry Report & Risk Adjusted Swing Trade Ideas - newser.com
Finanzdaten der Edwards Lifesciences Corp-Aktie (EW)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.94%
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):